GlassScriptPhysician profile
William A Cutchen
NPI 1407201668
$969.18
in general payments reported to CMS, 2019-2025
13 companies · $229 in 2025
The $229 reported for 2025 was less than what a typical Pediatric Orthopaedic Surgery provider received nationally (typical 2025 total: $271).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $19.52 · 2022: $113 · 2023: $149 · 2024: $459 · 2025: $229.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $776 · Entertainment: $61.26.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $775.73 |
| Entertainment | $61.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biocomposites INC | $302.41 | 2024-2025 | Stimulan |
| Prime Surgical, LLC | $129.71 | 2024 | |
| Zimmer Biomet Holdings, INC. | $112.67 | 2022 | |
| Depuy Synthes Sales INC. | $94.43 | 2023 | Na |
| Kerecis Limited | $72.84 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Djo, LLC | $60.62 | 2024 | Cmf |
| Smith+Nephew, INC. | $54.57 | 2023 | Smart Tsf, Spatial Frame |
| Bioventus LLC | $35.12 | 2024-2025 | Exogen Ultrasound Bone Healing System, Bonescalpel & Sonicone (O.R.) |
| Ossur Americas, INC. | $26.85 | 2025 | |
| Molnlycke Health Care US, LLC | $23.31 | 2024 | Mepilex Border Sacrum, Mepilex Border Flex |
| Vertex Pharmaceuticals Incorporated | $20.46 | 2025 | |
| Baxter Healthcare | $19.52 | 2021 | |
| Curonix LLC | $16.67 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Cutchen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.